While Abbott Laboratories was capturing headlines for its acquisition of a chunk of India’s Piramal, a Southern Hemisphere deal took aim at the top spot in Australia’s prescription drug market. Africa’s biggest drugmaker, Aspen Pharmacare, launched a takeover bid for Australia’s Sigma Pharmaceuticals, taking advantage of the latter’s recent…
Will some DTC foes use the FDA’s new “Bad Ad” program to crusade against the very idea of consumer advertising for drugs? That’s what some industry-watchers predict in an Advertising Age analysis of the agency initiative. The FDA recently unveiled the “Bad Ad” push, asking doctors to help catch…
Aspen Pharmacare Holdings, Africa’s largest drug company, offered to buy Sigma Pharmaceuticals for about A$1.49 billion ($1.24 billion) in cash and assumed debt to expand in Australia. Report
Original Source of Aspen bids $1.24B for Australia’s troubled Sigma Pharma
Johnson & Johnson’s ( NYSE: JNJ ) highly publicized manufacturing troubles could stem from a management trend toward decentralization and business-unit autonomy, BNet Pharma reports, quoting sources. Back in 2005 and 2006, J&J operating company managers successfully fought to loosen the apron strings from their corporate parent, the sources…
The European Medicines Agency has
More cancer drugs are showing promise at keeping the disease at bay when they’re used as maintenance treatments. Rituxan , marketed by Roche’s Genentech unit and Biogen Idec ( NASDAQ: BIIB ), cut the risk of lymphoma relapse by half when used for two years after initial treatment was…
Abbott Laboratories ( NYSE: ABT )
Abbott (NYSE: ABT) announced a definitive agreement with Piramal Healthcare Limited to acquire full ownership of Piramal’s Healthcare Solutions business (Domestic Formulations), a leader in the Indian branded generics market, for an up-front payment of $2.12 billion, plus $400 million annually for the next four years, giving Abbott the No….
Harvard School of Public Health (HSPH) researchers and colleagues seeking to block invasion of healthy red blood cells by malaria parasites have instead succeeded in locking the parasites within infected blood cells, potentially containing the disease.
Original Source of New Twist on Potential Malaria Drug Target Acts by Trapping Parasites…
9-10 February 2011, Budapest, Hungary. The PHARM Connect Congress 2011, an event organised by The Events Group, offers the perfect setting for solution providers to present their products and services directly to key decision makers of target client population throughout Central & Eastern Europe.
Original Source of The PHARM Connect…